China Beauty Update: NMPA Filing Changes in 2026 — Key Takeaways
On 28 January 2025, China’s 国家药品监督管理局 (National Medical Products Administration, NMPA, guójiā yàopǐn jiāndū guǎnlǐ jú) released a consultation draft proposing 5 major changes to cosmetic filing rules that will take full effect from 1 January 2026 — tightening safety documentation, expanding digital submission requirements, raising penalties for non-compliance, and creating new exemptions for low-risk products, affecting an estimated 15,000+ foreign and domestic beauty brands operating in China.
Background: Why the 2026 Filing Shake-Up Matters
China’s beauty market surpassed ¥1.2 trillion in retail sales in 2024 — roughly 18% of the global market — yet foreign brands have faced increasing friction under the 2021 Cosmetic Supervision and Administration Regulation (CSAR). The NMPA’s 2026 proposals aim to close three specific gaps: inconsistent animal testing exemption enforcement, incomplete digital record submission, and vague “new ingredient” classification. For overseas brands, these changes mean higher upfront compliance costs but also clearer pathways for faster market entry.
The draft specifically targets the 化妆品备案 (cosmetic filing, huàzhuāngpǐn bèi’àn) process — distinct from registration — which covers 95% of daily-use beauty products (creams, sunscreens, shampoos) that do not require full drug-style approval. Under current rules, a foreign brand can file a product in 60–90 days. In 2026, that timeline is expected to stretch to 120–150 days due to new data requirements.
| Requirement | Current (2025) | 2026 Proposed | Impact on Foreign Brands |
|---|---|---|---|
| Safety report submission | Summary only (5–10 pages) | Full toxicological dossier | +¥50,000–80,000 per SKU |
| Digital submission window | Any time pre-launch | 90-day mandatory pre-filing period | Delays launch by 1–3 months |
| Animal testing waiver renewal | Automatic (once granted) | Required every 3 years | Annual cost: ¥20,000+ per SKU |
| Low-risk product exemption list | None | New “Green Channel” for 8 categories | 50% faster filing for qualifying products |
| Penalty for false documentation | ¥30,000–100,000 fine | ¥500,000–2,000,000 + product recall | Increased legal exposure |
Key Changes in the 2026 Filing Reforms
1. Full Toxicological Dossier Now Mandatory
The most disruptive change is the shift from a summary safety report to a complete toxicological dossier — mirroring requirements in the European Union and Japan. Foreign brands must submit in vitro and in silico test data for each ingredient at concentrations above 0.1% in rinse-off products and 0.01% in leave-on products. This adds an estimated ¥60,000–120,000 per product SKU for third-party testing in China or accredited overseas labs.
Brands that already have EU-level safety dossiers can convert them into NMPA format, but must have them translated and certified by a Chinese notary — a process that adds 4–6 weeks and ¥15,000–25,000 in administrative costs. The NMPA estimates that 30% of current foreign brand filings would need additional data under the new rules.
2. 90-Day Pre-Filing Window Becomes Mandatory
Currently, foreign brands can submit a cosmetic filing and begin selling immediately — as long as the filing is accepted. From 2026, all new submissions require a mandatory 90-day “pre-filing” period during which the NMPA can request clarifications. If no response is received within 30 days, the filing is automatically rejected and must be resubmitted — costing another ¥10,000 in filing fees plus re-testing if the product formula has changed.
This means a brand planning a Spring Festival 2026 launch must start the filing process by October 2025 at the latest. The NMPA has stated that this window is intended to catch safety documentation errors early, reducing post-market recalls by an estimated 40%.
3. New “Green Channel” Exemptions for Low-Risk Products
To offset the added burden, the NMPA has proposed eight product categories eligible for expedited filing. These include simple rinse-off cleansers, basic moisturizers without active ingredients, and fragrance-free shampoos. Qualifying products can skip the 90-day pre-filing window and proceed with a simplified 14-day filing process — a 70% reduction in timeline.
To qualify, a product must: (a) contain no ingredients on the NMPA’s “Active Monitoring List” (currently 42 substances); (b) have a pH between 4.5 and 8.0; and (c) be manufactured at a facility with ISO 22716 certification. The NMPA expects 20% of all foreign brand filings to fall under this channel in 2026.
Impact on Foreign Beauty Brands
Cost Increases and Compliance Burdens
For an average foreign beauty brand launching 10 new SKUs per year, the total incremental cost from the 2026 changes is estimated at ¥800,000–1,200,000 — a 40–60% increase over current compliance costs. This includes testing, translation, legal review, and the staff time required to manage 90-day pre-filings.
Smaller indie brands — those with fewer than 50 SKUs globally — will be hit hardest. The NMPA’s own impact assessment notes that 65% of “micro-size foreign applicants” (filing ≤5 products annually) may exit the Chinese market or switch to distribution-only models where a Chinese partner holds the filing.
Testing and Animal Welfare Implications
For non-special-use cosmetics (general skincare, makeup, haircare), China’s post-2021 animal testing waiver for products manufactured in China has allowed thousands of foreign “cruelty-free” brands to enter. The 2026 reforms renew that waiver but require re-certification every three years — meaning new safety documentation must be submitted even if the product formula has not changed. Brands that rely on imported finished products (not locally manufactured) may face renewed animal testing unless their home country’s testing standards are recognized under mutual agreements — currently only the EU, Japan, and Australia qualify.
Compliance Timeline and Next Steps for Brands
The NMPA consultation period runs until 30 April 2025, with the final regulation expected by 1 September 2025. Brands should begin auditing their current filings now to identify which products will need additional data.
Key deadlines:
- By 30 June 2025: Complete internal audit of all active NMPA filings for formula changes or incomplete documentation.
- By 1 October 2025: Submit first voluntary filings under the new toxicological dossier rules (early adopters receive priority review).
- From 1 January 2026: All new submissions must comply with the 90-day pre-filing window and full dossier requirements.
The NMPA will hold two open briefings in Shanghai (March 2025) and Guangzhou (April 2025) for foreign trade associations — including the European Chamber of Commerce and AmCham China — to clarify the new rules.
NEXT STEPS
- Audit your current NMPA filings against the new toxicological dossier requirements. Start with your top 10 SKUs by revenue — read our NMPA Filing Audit Checklist for a step-by-step template.
- Register for the NMPA’s Shanghai briefing (10 March 2025) — limited to 200 attendees. See the 2025 NMPA Beauty Briefing Calendar for registration links.
- Begin your 90-day pre-filing test run in Q2 2025 with one low-risk product to understand the process. Our team offers a Pre-Filing Simulation Service for ¥9,800 per product.
— China Gateway 360 —
Remote China market entry support, built around execution.
